• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reduce unnecessary use of proton pump inhibitors.

作者信息

Farrell Barbara, Lass Elliot, Moayyedi Paul, Ward Deanna, Thompson Wade

机构信息

Bruyère Research Institute, Ottawa, ON, Canada.

Department of Family Medicine, University of Ottawa, Ottawa, ON, Canada.

出版信息

BMJ. 2022 Oct 24;379:e069211. doi: 10.1136/bmj-2021-069211.

DOI:10.1136/bmj-2021-069211
PMID:36280250
Abstract
摘要

相似文献

1
Reduce unnecessary use of proton pump inhibitors.减少质子泵抑制剂的不必要使用。
BMJ. 2022 Oct 24;379:e069211. doi: 10.1136/bmj-2021-069211.
2
Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.胃食管反流病中幽门螺杆菌检测与治疗策略的理论依据
Gastroenterol Clin North Am. 2015 Sep;44(3):661-6. doi: 10.1016/j.gtc.2015.05.007. Epub 2015 Jun 19.
3
Diagnosis of Helicobacter pylori Infection in the Proton Pump Inhibitor Era.质子泵抑制剂时代幽门螺杆菌感染的诊断
Gastroenterol Clin North Am. 2015 Sep;44(3):507-18. doi: 10.1016/j.gtc.2015.05.001. Epub 2015 Jun 20.
4
Drugs for peptic ulcer disease and GERD.用于消化性溃疡疾病和胃食管反流病的药物。
Treat Guidel Med Lett. 2011 Sep;9(109):55-60; quiz 2 p following 60.
5
Gastroesophageal reflux disease and the relationship with Helicobacter pylori.胃食管反流病及其与幽门螺杆菌的关系。
Turk J Gastroenterol. 2017 Dec;28(Suppl 1):S61-S67. doi: 10.5152/tjg.2017.16.
6
[Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].[当前护理指南更新。当前护理指南：复发性上消化道症状]
Duodecim. 2012;128(22):2376-7.
7
[Evidence and uncertainties on the clinical use of proton pump inhibitors].[质子泵抑制剂临床应用的证据与不确定性]
Gastroenterol Hepatol. 2010 May;33 Suppl 1:5-10. doi: 10.1016/S0210-5705(10)70002-9.
8
ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.小儿胃食管反流病的抗分泌治疗——一项系统评价
Arq Gastroenterol. 2017 Dec;54(4):271-280. doi: 10.1590/S0004-2803.201700000-42. Epub 2017 Sep 21.
9
[Are proton pump inhibitors effective in asthmatics with gastroesophageal reflux disease?].质子泵抑制剂对患有胃食管反流病的哮喘患者有效吗？
Korean J Gastroenterol. 2011 Oct 25;58(4):169-70. doi: 10.4166/kjg.2011.58.4.169.
10
Esomeprazole: a proton pump inhibitor.埃索美拉唑：一种质子泵抑制剂。
Expert Rev Gastroenterol Hepatol. 2009 Feb;3(1):15-27. doi: 10.1586/17474124.3.1.15.

引用本文的文献

1
Evaluating the risk of osteoporosis-related adverse events with proton pump inhibitors: a pharmacovigilance study.评估质子泵抑制剂相关骨质疏松不良事件的风险：一项药物警戒研究。
Front Pharmacol. 2025 Jul 11;16:1582908. doi: 10.3389/fphar.2025.1582908. eCollection 2025.
2
Preoperative proton pump inhibitor therapy and anastomotic leak after esophagectomy-a new perspective.术前质子泵抑制剂治疗与食管癌切除术后吻合口漏——一个新视角
Langenbecks Arch Surg. 2025 May 14;410(1):157. doi: 10.1007/s00423-025-03727-3.
3
Proton pump inhibitors and 1-year risk of adverse outcomes after discharge from internal medicine wards: an observational study in the REPOSI cohort.
质子泵抑制剂与内科病房出院后不良结局的1年风险：REPOSI队列中的一项观察性研究
Intern Emerg Med. 2025 Apr 6. doi: 10.1007/s11739-025-03937-z.
4
Review Article: Individualised Management of Reflux-Like Symptoms-Strategies Beyond Acid Suppression.综述文章：胃食管反流样症状的个体化管理——抑酸以外的策略
Aliment Pharmacol Ther. 2025 May;61(9):1437-1446. doi: 10.1111/apt.70115. Epub 2025 Apr 1.
5
Effects of the Nudge Theory-Based Multifaceted Intervention on Reducing Inappropriate Proton Pump Inhibitors Use for Prophylaxis in Hospitalized Patients: A Non-Randomized Controlled Study.基于助推理论的多方面干预对减少住院患者预防性使用不当质子泵抑制剂的影响：一项非随机对照研究。
J Gen Intern Med. 2025 Mar 19. doi: 10.1007/s11606-025-09460-3.
6
So Many Choices, So Little Value: Potential Savings from Selecting Cost-Effective Proton Pump Inhibitors.选择众多，价值寥寥：选用性价比高的质子泵抑制剂可能节省的费用
Pharmacoecon Open. 2025 May;9(3):461-469. doi: 10.1007/s41669-025-00563-5. Epub 2025 Feb 13.
7
Effectiveness of a Pharmacist-Led Intervention to Reduce Acid Suppression Therapy for Stress Ulcer Prophylaxis in ICUs in China: A Multicenter, Stepped-Wedge, Cluster-Randomized Controlled Trial.药师主导的干预措施在中国重症监护病房减少应激性溃疡预防的抑酸治疗的有效性：一项多中心、阶梯式楔形、整群随机对照试验
Crit Care Med. 2025 Jan 31;53(4):e805-16. doi: 10.1097/CCM.0000000000006589.
8
Proton Pump Inhibitor Use and Incident Cardiovascular Disease in Older Postmenopausal Women.老年绝经后女性使用质子泵抑制剂与心血管疾病的发生
J Am Geriatr Soc. 2025 Feb;73(2):411-421. doi: 10.1111/jgs.19326. Epub 2024 Dec 31.
9
Current study of pathogenetic mechanisms and therapeutics of chronic atrophic gastritis: a comprehensive review.慢性萎缩性胃炎发病机制与治疗的当前研究：一项综述
Front Cell Dev Biol. 2024 Dec 10;12:1513426. doi: 10.3389/fcell.2024.1513426. eCollection 2024.
10
Association between proton pump inhibitors and dementia risk: a Mendelian randomization study.质子泵抑制剂与痴呆风险的关联：一项孟德尔随机化研究。
Sci Rep. 2024 Nov 19;14(1):28624. doi: 10.1038/s41598-024-79821-1.